Colonic drug delivery can facilitate access to unique therapeutic targets and has the
potential to enhance drug bioavailability whilst reducing off-target effects. Delivering drugs to …

Identification of patients at risk for postpartum hemorrhage (PPH) may allow for prompt
diagnosis and intervention. Individual risk factors, risk assessment tools and prediction …

In the absence of comprehensive data investigating carbetocin versus misoprostol for
reducing postpartum hemorrhage (PPH) during cesarean section (CS), we performed this …

Background The prostaglandin E1 analog “misoprostol” is a drug that has powerful ecbolic
effects and can be beneficial in the prevention and treatment of postpartum hemorrhage …

Globally, postpartum hemorrhage (PPH) is the top cause of maternal death. Multiple
uterotonic medications are available to prevent PPH; however, it is still unclear whether one …

During the third stage of labor, oxytocin and tranexamic acid, oxytocin and misoprostol,
oxytocin and methylergometrine, or carbetocin is recommended for the prevention of …

Post-partum haemorrhage (PPH) contributes to approximately 25% of maternal death
globally. Tranexamic acid (TXA) has been confirmed to be effective in reducing post-partum …

Background: Over 25% of all maternal deaths, especially in low-income nations, are
attributed to postpartum hemorrhage (PPH), in accordance with the World Health …

Background: Postpartum hemorrhage (PPH) is a leading cause of maternal morbidity and
mortality, particularly in cesarean deliveries where uterine atony remains a significant risk …

Objective: The objective was to compare the mean1blood loss using sublingual misoprostol
and intravenous oxytocin infusion in primigravidas undergoing caesarean section at term …